Поиск
Закладки
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Бариатрическая и метаболическая хирургия

References

  1. Finucane MM et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011;377:557-67.
  2. World Health Organization (WHO), available at: http://www.euro.who.int/en/what-we-do/health-topics/noncommunicable-diseases/obesity
  3. World Health Organization (WHO), Fact Sheet No.311 (updated March 2013) available at: http://www.who.int/mediacentre/factsheets/fs311/en/
  4. Frühbeck G, Toplak H, Woodward E, Yumuk V, Maislos M, Oppert JM. Obesity: The gateway to ill health - an EASO Position Statement on a rising public health, clinical and scientific challenge in Europe. Obes Facts 2013;6:117-20.
  5. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012;307:491-7.
  6. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA 2012;307:483-90.
  7. Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes (London) 2008; 32:1431–1437.
  8. Finkelstein EA, Trogdon JG, Cohen JW, Dietz W. Annual medical spending attributable to obesity: payer- and service-specific estimates. Health Aff (Millwood) 2009;28: w822-w831.
  9. Frühbeck G. Obesity: Screening for the evident in obesity. Nat Rev Endocrinol 2012;8:570-572.
  10. Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial – a prospective controlled intervention study of bariatric surgery. J Intern Med 2013;273:219-234.
  11. Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, Moore SC, Tobias GS, Anton-Culver H, Freeman LB, Beeson WL, Clipp SL, English DR, Folsom AR, Freedman DM, Giles G, Hakansson N, Henderson KD, Hoffman-Bolton J, Hoppin JA, Koenig KL, Lee IM, Linet MS, Park Y, Pocobelli G, Schatzkin A, Sesso HD, Weiderpass E, Willcox BJ, Wolk A, Zeleniuch-Jacquotte A, Willett WC, Thun MJ. Body-mass index and mortality among 1.46 million white adults. N Engl J Med 2010;363:2211-2219.
  12. Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 2013;309:71-82.
  13. Neovius M, Narbro K, Keating C, Peltonen M, Sjöholm K, Agren G,Sjöström L, Carlsson L. Health care use during 20 years following bariatric surgery. JAMA 2012;308:1132-1141.
  14. Fried M, Hainer V, Basdevant A, Buchwald H, Deitel M, Finer N, Greve JMM, Horber F, Mathus-Vliegen E, Scopinaro N, Steffen R, Tsigos C, Weiner R, Widhalm K. Interdisciplinary European guidelines on surgery of severe obesity. Obes Facts 2008;1:52-59.
  15. Lehman Center Weight Loss Surgery Expert Panel: Commonwealth of Massachusetts Betsy Lehman Center for Patient Safety and Medical Error Reduction Expert Panel on weight loss surgery: executive report. Obes Res 2005;13:205–305.
  16. Sauerland S, Angrisani L, Belachew M, Chevallier JM, Favretti F, Finer N, et al: Obesity surgery. Evidence based guidelines of the EAES. Surg Endosc 2005;19:200–221.
  17. Maggard MA, Shugarman ML, Suttorp M, Maglione M, Sugerman HJ, Livingston EH, et al: Meta-analysis: surgical treatment of obesity. Ann Int Med 2005;142:547–559.
  18. Laville M, Romon M, Chavrier G, Guy-Grand B, Krempf M, Chevallier JM, et al: Recommendations regarding obesity surgery. Obes Surg 2005;15:1476–1480.
  19. Mechanick JI, Youdim A, Jones DB, Garvey WT, Hurley DL, McMahon MM, Heinberg LJ, Kushner R, Adams TD, Shikora S, Dixon JB, Brethauer S: AACE/TOS/ASMS Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient-2013 update: cosponsored by american association of clinical endocrinologists, the obesity society, and american society for metabolic & bariatric surgery. Endocr Pract 2013;19:337-72.
  20. NIH Conference: Gastrointestinal surgery for severe obesity. Consensus development konference panel. Ann Intern Med 1991;115:956–961.
  21. Ridley N: Expert panel on weight loss surgery – executive report. Obes Res 2005;13:206–226.
  22. Andersen T, Backer OG, Stokholm KH, Quaade F: Randomized trial of diet and gastroplasty compared with diet alone in morbid obesity. N Engl J Med 1984;310:352–356.
  23. Andersen T, Stokholm KH, Backer OG, Quaade F: Long term (5-year) results after either horizontal gastroplasty or very low-calorie diet for morbid obesity. Int J Obes 1988;12:277–284.
  24. Karason K, Lindroos AK, Stenlof K, Sjostrom L: Relief of cardiorespiratory symptoms and increased physical activity after surgically induced weight loss: results from the Swedish Obese Subjects study. Arch Intern Med 2000;160:1797–1802.
  25. Karlsson J, Sjostrom L, Sullivan M:Swedish Obese Subjects (SOS) an intervention study of obesity. Two-year follow-up of health-related quality of life (HRQL) and eating behavior after gastric surgery for severe obesity. Int J Obes Relat Metab Disord 1998;22:113–126.
  26. Fernandez AZ Jr, Demaria EJ, Tichansky DS, Kellum JM, Wolfe LG, Meador J: Multivariate analysis of risk factors for death following gastric bypass for treatment of morbid obesity. Ann Surg 2004;239: 698–703.
  27. Sjostrom CD, Peltonen M, Wedel H, Sjostrom L: Differentiated long-term effects of intentional weight loss on diabetes and hypertension. Hypertension 2000;36:20–25.
  28. Sjostrom CD, Lissner I, Wedel H, Sjostrom L: Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res 999;7:477–484.
  29. Christou NV, Sampalis JS, Liberman M, Look D, Auger S, McLean A, et al: Surgery decreases longterm mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 2004;240: 416–423.
  30. Mun EC, Blackburn GL, Matthews JB: Current status of medical and surgical therapy for obesity. Gastroenterology 2001;120:669–681.
  31. Flum DR, Dellinger E: Impact of gastric bypass on survival: a population-based analysis. J Am Coll Surg 2004;199:543–551.
  32. American College of Endocrinology (ACE), American Association of Clinical Endocrinologists (AACE): AACE/ACE position statement on the prevention, diagnosis and treatment of obesity. Jacksonville, American Association of Clinical Endocrinologists, 1998.
  33. American Society for Bariatric Surgery, Society of American Gastrointestinal Endoscopic Surgeons: Guidelines for laparoscopic and open surgical treatment of morbid obesity. Obes Surg 2000;10: 378–379.
  34. Douketis JD, Feightner JW, Attia J, Feldman WF, with the Canadian Task Force on Preventive Health Care: Periodic health examination, 1999 update 1. Detection, prevention and treatment of obesity. CMAJ 1999;160:513–525.
  35. International Federation for the Surgery of Obesity: Statement on patient selection for bariatric surgery. Obes Surg 1997;7:41.
  36. Lauterbach K, Westenhofer J, Wirth A, Hauner H: Evidenz-basierte Leitlinie zur Behandlung der Adipositas in Deutschland. Köln, Otto Hauser, 1998.
  37. Msika S: Surgery for morbid obesity: 2. Complications.Results of a technologic evaluation by the ANAES. J Chir (Paris) 2003;140:4–21.
  38. National Institute for Clinical Excellence: 2002 Guidance on the use of surgery to aid weight reduction for people with morbid obesity (Technology Appraisal No 46). National Institute for Clinical Excellence, London, 2002.
  39. Pontiroli AEW, Morabito A. Long-term prevention of mortality in morbid obesity through bariatric surgery. A systematic review and meta-analysis of trials performed with gastric banding and gastric bypass. Ann Surg 2011; 253: 484-487. Erratum in: Ann Surg 2011; 253: 1056.
  40. Buchwald H, Rudser KD, Williams SE, et al. Overall mortality, incremental life expectancy, and cause of death at 25 years in the program on the surgical control of the hyperlipidemias. Ann Surg 2010; 251: 1034-1040.
  41. Padwal R, Klarenbach S, Wiebe N, et al. Bariatric surgery: a systematic review and network meta-analysis of randomized trials. Obes Rev 2011; 12:602-621. doi: 10.1111/j.1467-789X.2011.00866.x. Epub 2011 Mar 28.
  42. Garb J, Welch G, Zagarins S, et al. Bariatric surgery for the treatment of morbid obesity: a meta-analysis of weight loss outcomes for laparoscopic adjustable gastric banding and laparoscopic gastric bypass. Obes Surg 2009; 19: 1447-1455.
  43. Valezi AC, Mali Junior J, de Menezes MA, et al. Weight loss outcome after silastic ring Roux-en Y gastric by-pass: 8 years of follow-up. Obes Surg 2010; 20: 1491-1495.
  44. Toouli J, Kow L, Ramos AC, et al. International multicenter study of safety and effectiveness of Swedish Adjustable Gastric Band in 1-, 3-, and 5-year follow-up cohorts. Surg Obes Relat Dis 2009; 5: 598-609.
  45. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systemic review and meta-analysis. Am J Med 2009; 122: 248-256.
  46. Hofsø D, Nordstrand N, Johnson LK, et al. Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. Eur J Endocrinol 2010; 163; 735-745.
  47. Hofsø D, Jenssen T, Bollerslev J, et al. Beta cell function after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. Eur J Endocrinol 2011; 164: 231-238.
  48. Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes. JAMA 2008; 299: 316-323.
  49. Lee WJ, Chong K, Ser KH, et al. Gastric bypass vs. sleeve gastrctomy for type 2 diabetes mellitus. Arch Surg 2011; 146: 143-148.
  50. Lee WJ, Wang W, Lee YC, et al. Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI > 35 and < 35. J Gastrointest Surg 2008; 12: 945-952.
  51. Cohen RV, Pinheiro JC, Schiavon CA, et al. Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care 2012; 35: 1420-1428.
  52. Choi J, Digiorgi M, Milone L, et al. Outcomes of laparoscopic adjustable gastric banding in patients with low body mass index. Surg Obes Relat Dis 2010; 6: 367-371.
  53. Serrot FJ, Dorman RB, Miller CJ, et al. Comparative effectiveness of bariatric surgery and nonsurgical therapy in adults with type 2 diabetes mellitus and body mass index < 35 kg/m2. Surgery 2011; 150: 684-691.
  54. Fried M, Ribaric G, Buchwald JN, et al. Metabolic surgery for the treatment of type 2 diabetes in patients with BMI < 35 kg/M2: an integrative review of early studies. Obes Surg 2010; 20: 776-790.
  55. Lee WJ, Chong K, Chen CY, et al. Diabetes remission and insulin secretion after gastric bypass in patients with body mass index < 35 kg/M2. Obes Surg 2011; 21: 889-895.
  56. Demaria EJ, Winegar DA, Pate VW, et al. Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS bariatric surgery center of excellence program as reported in the Bariatric Outcomes Longitudinal Database. Ann Surg 2010; 252: 559-566.
  57. Lee WJ, Ser KH, Chong K, et al. Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion. Surgery 2010; 147: 664-669.
  58. Buse JB, Caprio S, Cefalu WT et al: How do we define cure of diabetes? Diabetes Care 2009; 32, 11: 2133-2135.
  59. Maggard-Gibbons M, Maglione M, Livhits M et al.: Bariatric Surgery for Weight Loss and Glycemic Control in Nonmorbidly Obese Adults With Diabetes. JAMA 2013; 309, 21:2250-2261.
  60. Ikramuddin S, Korner J, Lee W-J et al.: Roux-en-Y Gastric Bypass vs Intensive Medical Management for theControl of Type 2Diabetes, Hypertension, and Hyperlipidemia. JAMA 2013; 309, 21:2240-2249.
  61. Apovian CM, Baker C, Ludwig DS, Hoppin AG, Hsu C, Lenders C, et al: Best practice guidelines in pediatric/adolescent weight loss surgery. Obes Res 2005;13:274–282.
  62. Inge TH, Krebs NF, Garcia VF, Skelton JA, Guice KS, Strauss RS, et al: Bariatric surgery for severely overweight adolescents: concerns and recommendations. Pediatrics 2004;114:217–223.
  63. Sugerman HJ, Sugerman EL, DeMaria EJ, Kellum JM, Kennedy C, Mowery Y, et al: Bariatric surgery for severely obese adolescents. J Gastrointest Surg 2003;7:102–107.
  64. Dolan K, Creighton L, Hopkins G, Fielding G: Laparoscopic gastric banding in morbidly obese adolescents. Obes Surg 2003;13:101–104.
  65. Stanford A, Glascock JM, Eid GM, Kane T, Ford HR, Ikramuddin S, et al: laparoscopic Roux-en-Y gastric bypass in morbidly obese adolescents. J Pediatr Surg 2003;38:430–433.
  66. Widhalm K, Dietrich S, Prager G: Adjustable gastric banding surgery in morbidly obese adolescents: experience with 8 patients. Int J Obes Relat Metab Disord 2004;28(suppl 3):42S–48S.
  67. Silberhummer GR, Miller K, Kriwanek S, Widhalm K, Pump A, Prager G: laparoscopic adjustable gastric banding in adolescents: the Austrian experience. Obes Surg 2006;16:1062–1067.
  68. Capella JF, Capella RF: Bariatric surgery in adolescence: is this the best age to operate? Obes Surg 2003;13:826–832.
  69. Patterson EJ, Urbach DR, Swanstrom LL: A comparison of diet and exercise therapy versus laparoscopic Roux-en-Y gastric bypass surgery for morbid obesity: a decision analysis model. J Am Coll Surg 2003;196:379–384.
  70. Averbukh Y, Heshka S, El-Shoreya H, Flancbaum L, Geliebter A, Kamel S, et al: Depression score predicts weight loss following Roux-en-Y gastric bypass. Obes Surg 2003;13:833–836.
  71. Ray EC, Nickels MW, Sayeed S, Sax HC: Predicting success after gastric bypass: the role of psychosocial and behavioral factors. Surgery 2003;134:555–564.
  72. Charles SC: Psychiatric evaluation of morbidly obese patients. Gastroenterol Clin North Am 1987; 16:415–432.
  73. Gertler R, Ramsey-Stewart G: Pre-operative psychiatric assessment of patients presenting for gastric bariatric surgery (surgical control of morbid obesity). Aust N Z J Surg 1986;56:157–161. |
  74. Guisado JA, Vaz FJ, Lopez-Ibor JJ, Lopez-Ibor MI, del Rio J, Rubio MA: Gastric surgery and restraint from food as triggering factors of eating disorders in morbid obesity. Int J Eat Disord 2002;31:97–100.
  75. Sogg S, Mori DL: The Boston interview for gastric bypass: determining the psychological suitability of surgical candidates. Obes Surg 2004;14:370–380.
  76. Ferraro DR: Preparing patients for bariatric surgery-the clinical considerations. Clin Rev 2004; 14:57–63.
  77. Naef M, Sadowski C, de Marco D, Sabbioni M, Balsiger B, Laederach K, et al: Die vertikale Gastroplastik nach Mason zur Behandlung der morbiden Adipositas: Ergebnisse einer prospektiven klinischen Studie. Chirurg 2000;71:448–455.
  78. Wiesner W, Schob O, Hauser RS, Hauser M: Adjustable laparoscopic gastric banding in patients with morbid obesity: radiographic management, results, and postoperative complications. Radiology 2000;216:389–394.
  79. Schumann R, Jones SB, Ortiz VE, Connor K, PulaiI, Ozawa ET, et al: Best practice recommendations for anesthetic perioperative care and pain management in weight loss surgery. Obes Res 2005;13:254–266.
  80. O’Keeffe T, Patterson EJ:. Evidence supporting routine polysomnography before bariatric surgery.Obes Surg 2004;14:23–26.
  81. Sugerman HJ, Fairman RP, Baron PL, Kwentus JA: Gastric surgery for respiratory insufficiency of obesity. Chest 1986;90:81–86.
  82. Sugerman HJ, Fairman RP, Sood RK, Engle K, Wolfe L, Kellum JM: Long-term effects of gastric surgery for treating respiratory insufficiency of obesity. Am J Clin Nutr 1992;55(suppl 2):597S–601S.
  83. Miller K, Hell E: Laparoscopic surgical concepts of morbid obesity. Langenbecks Arch Surg 2003;388: 375–384.
  84. Naef M, Sadowski C, de Marco D, Sabbioni M, Balsiger B, Laederach K, et al: Die vertikale Gastroplastik nach Mason zur Behandlung der morbiden Adipositas: Ergebnisse einer prospektiven klinischen Studie. Chirurg 2000;71:448–455.
  85. Gonzalez R, Bowers SP, Venkatesh KR, Lin E, Smith CD: Preoperative factors predictive of complicated postoperative management after Roux-en- Y gastric bypass for morbid obesity. Surg Endosc 2003;17:1900–1914.
  86. Frey WC, Pilcher J: Obstructive sleep-related breathing disorders in patients evaluated for bariatric surgery. Obes Surg 2003;13:676–683.
  87. Sharaf RN, Weinshel EH, Bini EJ, Rosenberg J, Ren CJ: Radiologic assessment of the upper gastrointestinal tract: does it play an important preoperative role in bariatric surgery? Obes Surg 2004; 14:313–317.
  88. Jaffin BW, Knoepflmacher P, Greenstein R: High prevalence of asymptomatic esophageal motility disorders among morbidly obese patients. Obes Surg 1999;9:390–395.
  89. Frigg A, Peterli R, Zynamon A, Lang C, Tondelli P: Radiologic and endoscopic evaluation for laparoscopic adjustable gastric banding: preoperative and follow-up. Obes Surg 2001;11:594–599.
  90. Greenstein RJ, Nissan A, Jaffin B: Esophageal anatomy and function in laparoscopic gastric restrictive bariatric surgery: implications for patient selection. Obes Surg 1998;8:199–206.
  91. Verset D, Houben JJ, Gay F, Elcheroth J, Bourgeois V, Van Gossum A: The place of upper gastrointestinal tract endoscopy before and after vertical banded gastroplasty for morbid obesity. Dig Dis Sci 1997;42:2333–2337.
  92. Saltzman E, Anderson W, Apovian CM, Hannah B, Alison C, Diana C-D, et al: Criteria for patient selection and multidisciplinary evaluation and treatment of the weight loss surgery patient. Obes Res 2005;13:234–243.
  93. Sogg S, DeAnna L.M: Psychosocial Evaluation for Bariatric Surgery: The Boston Interview and Opportunities for Intervention. Obes Surg 2009;19:369–77.
  94. Heinberg LJ, Ashton K, Windover A. Moving beyond dichotomous psychological evaluation: The Cleveland Clinic Behavioral Rating System for Weight Loss Surgery. Surg Obes Relat Dis. 2010;6:185-90.
  95. Greenberg I, Sogg S, Perna FM. Behavioral and psychological care in weight loss surgery: Best practice update. Obesity. 2009;17:880-4.
  96. Mahony D. Psychological assessments of bariatric surgery patients. Development, reliability, and exploratory factor analysis of the PsyBari. Obes Surg. 2011; 21: 1395-1406.
  97. Fabricatore AN, Crerand CE, Wadden TA, et al. How do mental health professionals evaluate candidates for bariatric surgery? Survey results. Obes Surg. 2005;15:567-73.
  98. Peacock JC, Zizzi SJ. An assessment of patient behavioral requirements pre- and post-surgery at accredited weight loss surgical centers. Obes Surg. 2011;21:1950-7.
  99. Bauchowitz AU, Gonder-Frederick LA, Olbrisch ME, et al. Psychosocial evaluation of bariatric surgery candidates: A survey of present practices. Psychosom Med. 2005;67:825-32.
  100. Gerbrand C.M. van Hout, MScl; Jack J. Jakimowicz, MD2; Frederiek A.M. Fortuin, MScl; Aline J.M. Pelle, MSca; Guus L. van Heck, PWeight Loss and Eating Behavior following Vertical Banded Gastroplasty, Obesity Surgery, 17, 1226-1234
  101. Kofman, MD, Lent MR, Swencionis C. Maladaptive Eating Paterns, Quality of Life, and Weight Outcomes Following Gastric Bypass: Results of an Internet Survey. Obsity 2010; 18: 1938-1943.
  102. Rutledge T, Groez LM, Savu M. Psychiatric Factors and Weight Loss Patterns Following Gastric Bypass Surgery in a Veteran Population. Obes Surg 2011; 21: 29-35.
  103. Odom J, Zalesin KC, Washington TL. Behavioral Predictors of Weight Regain after Bariatric Surgery. 2010;20:349-356.
  104. Colles, S.L., Dixon, J.B., O'Brien, P.E.: Grazing and Loss of Control Related to Eating: Two High-risk Factors Following Bariatric Surgery. Behavior and Psychology, Obesity (2008) 16 3, 615–622.
  105. Kruseman M, Leimgruber A, Zumbach F, et al. Dietary, weight, and psychological changes among patients with obesity, 8 years after gastric bypass. J Am Diet Assoc 2010; 110: 527-534.
  106. deZwaan M, Mitchell JE, Howell LM, et al. Characteristics of morbidly obese patients before gastric bypass surgery. Compr Psychiatry 2003;44:428-434.
  107. Hsu LK, Benotti PN, Dwyer J, et al. W. Nonsurgical factors that influence the outcome of bariatric surgery: A review. Psychosomatic Med 1998; 60: 338-346.
  108. Guisado Macias JA, Vaz Leal FJ. Psychopathological differences between morbidly obese binge eaters and non-binge eaters after bariatric surgery. Eat Weight Dis 2003; 8: 315-318.
  109. Sabbioni ME, Dickson MH, Eychmueller S, et al. Intermediate results of health related quality of life after vertical banded gastroplasty. Int J Obes Relat Metab Disord 2002; 26: 277-280.
  110. Toussi R, Fujioka K, Coleman KJ. Pre-and postsurgery behavioral compliance, patient health, and postbariatric surgical weight loss. Obesity 2009;17:966-1002.
  111. Sarwer DB, Wadden TA, Fabricatore AN. Psychosocial and behavioral aspects of bariatric surgery. Obes Res 2005; 13: 639-648.
  112. de Zwaan M, Hilbert A, Swan-Kremeier L, et al. Comprehensive interview assessment of eating behavior 18-35 months after gastric bypass surgery for morbid obesity. Surg Obes Relat Dis 2010; 6: 79-87.
  113. White MA, Kalarchian M, Masheb RM, et al. Loss of control over eating predicts outcomes in bariatric surgery patients: a porspective, 24-month follow-up study. Jn of Clin Psychiatry 2010; 71: 175-184.
  114. Sarwer DB, Dilks RJ, West-Smith L. Dietary intake and eating behavior after bariatric surgery: Threats to weight loss maintenance and strategies for success. Surg Obes Rel Dis 2011; 7: 644-51.
  115. Ashton K, Heinberg L, Windover A, et al. Positive response to binge eating intervention enhances postsurgical weight loss and adherence. Surg Obes Relat Dis 2011; 7: 315-320.
  116. Korner J, Inabnet W, Febres G, et al. Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass. Int J Obes (Lond) 2009;33:786-95.
  117. Laferrere B, Teixeira J, McGinty J, et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab 2008;93:2479-85.
  118. Bose M, Teixeira J, Olivan B, et al. Weight loss and incretin responsiveness improve glucose control independently after gastric bypass surgery. J Diabetes;2:47-55.
  119. Vidal J, Ibarzabal A, Romero F, et al. Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects. Obes Surg 2008;18:1077-82.
  120. Leslie DB, Dorman RB, Serrot FJ, et al. Efficacy of the Roux-en-Y gastric bypass compared to medically managed controls in meeting the American Diabetes Association composite end point goals for management of type 2 diabetes mellitus. Obes Surg 2012; 22: 367-374.
  121. Carlsson LM, Peltonen M, Ahlin S, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med 2012; 367: 695-704.
  122. Arterburn DE, Bogart A, Sherwood NE, et al. A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obes Surg 10.1007/s11695-012-0802-1.
  123. Laferrere B. Effect of gastric bypass surgery on the incretins. Diabetes Metab 2009;35:513-7.
  124. Kashyap SR, Daud S, Kelly KR, et al. Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes. Int J Obes (Lond) 2009. 2010;34:462-71.
  125. Peterli R, Wolnerhanssen B, Peters T, et al. Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. Ann Surg 2009;250:234-41.
  126. Mingrone G, Castagneto-Gissey L. Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery. Diabetes Metab 2009;35:518-23.
  127. Briatore L, Salani B, Andraghetti G, et al. Beta-cell function improvement after biliopancreatic diversion in subjects with type 2 diabetes and morbid obesity. Obesity (Silver Spring);18:932-6.
  128. Briatore L, Salani B, Andraghetti G, et al. Restoration of acute insulin response in T2DM subjects 1 month after biliopancreatic diversion. Obesity (Silver Spring) 2008;16:77-81.
  129. Talebpour M, Amoli BS. Laparoscopic total gastric vertical plication in morbid obesity. J Laparoendosc Adv Surg Tech A 2007;17:793-8.
  130. Skrekas G, Antiochos K, Stafyla VK. Laparoscopic gastric greater curvature plication: results and complications in a series of 135 patients. Obes Surg 2011;21:1657-63.
  131. Ramos A, Galvao Neto M, Galvao M, Evangelista LF, Campos JM, Ferraz A. Laparoscopic greater curvature plication: initial results of an alternative restrictive bariatric procedure. Obes Surg 2010;20:913-8.
  132. Brethauer SA, Harris JL, Kroh M, et al. Laparoscopic gastric plication for treatment of severe obesity. Surg Obes Relat Dis 2011;7:15-22.
  133. National Institute for Health and Clinical Excellence (NICE) Interventional Procedure Guidance 432: Laparoscopic gastric plication for the treatment of severe obesity. www.guidance.nice.org.uk/pg432, 2012
  134. Fried M, Dolezalova K, Buchwald JN et al. Laparoscopic greater curvature plication (LGCP) for the treatment of morbid obesity in a series of 244 patiens. Obes Surg 2012;22: 1298-1307.
  135. Sánchez-Pernaute A, Rubio MA, Pérez-Aguirre ME et al. Single-anastomosis duodenoileal bypass with sleeve gastrectomy: metabolic improvement and weight loss in fierst 100 patients Surg Obes Relat Dis. 2012 Aug 7. (Epub ahead of print).
  136. Reoch J, Mottillo S, Shimony A, et al. Safety of laparoscopic vs open bariatric surgery: a systematic review and meta-analysis. Arch Surg 2011;146:1314-22.
  137. Kelly J, Tarnoff M, Shikora S, Thayer B, Jones DB, Forse RA, et al:. Best practice recommendations for surgical care in weight loss surgery. Obes Res 2005;13:227–233.
  138. Brolin RE: Bariatric surgery and long-term control of morbid obesity. JAMA 2002;288:2793–2796.
  139. Mun EC, Blackburn GL, Matthews JB: Current status of medical and surgical therapy for obesity. Gastroenterology 2001; 120: 669–681.
  140. Murr MM, Balsiger BM, Kennedy FP, Mai JL, Sarr MG: malabsorptive procedures for severe obesity: comparison of pancreaticobiliary bypass and very very long limb Roux-en-Y gastric bypass. J Gastrointest Surg 1999;3:607–612.
  141. Scopinaro N, Gianetta E, Adami GF, Friedman D, Traverso E, Marinari GM, et al: Biliopancreatic diversion for obesity at eighteen years. Surgery 1996;119:261–268.
  142. Scopinaro N, Marinari GM, Camerini G: Laparoscopic standard biliopancreatic diversion: technique and preliminary results. Obes Surg 2002;12:362–365.
  143. Howard L, Malone M, Michalek A, Carter J, AlgerS, Van Woert J: Gastric bypass and vertical banded gastroplasty – a prospective randomized comparison and 5-year follow-up. Obes Surg 1995;5:55–60.
  144. van Dielen FM, Soeters PB, de Brauw LM, Grewe JW: Laparoscopic adjustable gastric banding versus open vertical banded gastroplasty: a rospective randomized trial. Obes Surg 2005;15:1292–1298.
  145. Brolin RE, Kenler HA, Gorman JH, Cody RP: Long-limb gastric bypass in the superobese. A prospective randomized study. Ann Surg 1992;215:387–395.
  146. Podnos YD, Jimenez JC, Wilson SE, Stevens CM, Nguyen NT: Complications after laparoscopic gastric bypass: a review of 3464 cases. Arch Surg 2003; 138:957–961.
  147. Perugini RA, Mason R, Czerniach DR, Novitsky YW, Baker S, Litwin DEM, et al: Predictors of complication and suboptimal weight loss after laparoscopic Roux-en-Y gastric bypass: a series of 188 patients. Arch Surg 2003;138:541–545.
  148. Nguyen NT, Rivers R, Wolfe BM: Factors associated with operative outcomes in laparoscopic gastric bypass. J Am Coll Surg 2003;197:548–555.
  149. Ren CJ, Weiner M, Allen JW: Favorable early results of gastric banding for morbid obesity: the American experience. Surg Endosc 2004;18:543–546.
  150. Rubenstein RB: Laparoscopic adjustable gastric banding at a US center with up to 3-year follow-up. Obes Surg 2002;12:380–384.
  151. O’Brien PE, Dixon JB, Brown W, Schachter LM, Chapman L, Burn AJ, et al: The laparoscopic adjustable gastric band (Lap-Band): a prospective study of medium-term effects on weight, health and quality of life. Obes Surg 2002;12:652–660.
  152. Spivak H, Favretti F: Avoiding postoperative complications with the LAP-BAND system. Am J Surg 2002;184(suppl 2):31S–37S.
  153. Belachew M, Belva PH, Desaive C: Long-term results of laparoscopic adjustable gastric banding for treatment of morbid obesity. Obes Surg 2002;12:564–568.
  154. DeMaria EJ, Sugerman HJ: A critical look at laparoscopic adjustable silicone gastric banding for surgical treatment of morbid obesity: does it measure up? Surg Endosc 2000;14:697–699.
  155. Favretti F, Cadiere GB, Segato G, Himpens J, Busetto L, De Marchi F, et al: Laparoscopic adjustable silicone gastric banding (Lap-Band): how to avoid complications. Obes Surg 1997;7:352–358.
  156. Fried M, Miller K, Kormanova K: Literature review of comparative studies of complications with Swedish band and Lap-Band. Obes Surg 2004;14:256–260.
  157. Fried M, Peskova M, Kasalicky M: Assessment of the outcome of laparoscopic nonadjustable gastric banding and stoma adjustable gastric anding: surgeon’s and patient’s view. Obes Surg 1998;8:45–48.
  158. Hall JC, Watts JM, O’Brien PE, Dunstan RE, Walsh JF, Slavotinek AH, et al: Gastric surgery for morbid obesity. The Adelaide Study. Ann Surg 1990;211:419–427.
  159. Laws HL, Piantadosi S: Superior gastric reduction procedure for morbid obesity: a prospective, randomized trial. Ann Surg 1981;193:334–340.
  160. Bajardi G, Ricevuto G, Mastrandrea G, Branca M, Rinaudo G, Cali F, et al: Surgical treatment of morbid obesity with biliopancreatic diversion and gastric banding: report on an 8-year experience involving 235 cases. Ann Chir 2000;125:155–162.
  161. Chapman AE, Kiroff G, Game P, Foster B, O’Brien PE, Ham J, et al: Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic literature review. Surgery 2004;135:326– 351.
  162. Dolan K, Hatzifotis M, Newbury L, Fielding G: A comparison of laparoscopic adjustable gastric banding and biliopancreatic diversion in superobesity. Obes Surg 2004;14:165–169.
  163. Lee WJ, Chong K, Ser KH, et al. Gastric bypass vs. sleeve gastrctomy for type 2 diabetes mellitus. Arch Surg 2011; 146: 143-148.
  164. Lee WJ, Wang W, Lee YC, et al. Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI > 35 and < 35. J Gastrointest Surg 2008; 12: 945-952.
  165. Cohen RV, Pinheiro JC, Schiavon CA, et al. Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care 2012; 35: 1420-1428.
  166. Choi J, Digiorgi M, Milone L, et al. Outcomes of laparoscopic adjustable gastric banding in patients with low body mass index. Surg Obes Relat Dis 2010; 6: 367-371.
  167. Scopinaro N, Adami GF, Papadia FS, Camerini G et al: Effects of Biliopanceratic Diversion on Type 2 Diabetes in Patients With BMI 25 to 35. Ann Surg 2011; 253, 4:699-703
  168. Ciangura C, Bouillot JL, Lloret-Linares C, Poitou C, Veyrie N, Basdevant A,
    Oppert JM. Dynamics of change in total and regional body composition after
    gastric bypass in obese patients. Obesity (Silver Spring) 2010;18:760-5.
  169. Jones DB, Provost DA, DeMaria EJ, Smith CD, Morgenstern L, Schirmer B:. Optimal management of the morbidly obese patient SAGES appropriateness conference statement. Surg Endosc 2004;18:1029–1037.
  170. American Society for Bariatric Surgery: Bariatric surgery: ASBS guidelines. www.lapsurgery.com 2004.
  171. Society of American Gastrointestinal Endoscopic Surgeons: Guidelines for institutions granting bariatric priviledges utilizing laparoscopic techniques. SAGES and the SAGES Bariatric Task Force. Surg Endosc 2003;17:2037–2040.
  172. Flum DR, Dellinger EP: Impact of gastric bypass operation on survival: a population-based analysis. J Am Coll Surg 2004;199:543–551.
  173. Schauer P, Ikramuddin S, Hamad G, Gourash W: The learning curve for laparoscopic Roux-en-Y gastric bypass is 100 cases. Surg Endosc 2003;17: 212–215.
  174. Wittgrove AC, Clark GW. Laparoscopic gastric bypass, Roux-en-Y-500 patients: technique and results with 3–60 months follow-up. Obes Surg 2000;10:233–239.
  175. Higa KD, Boone KB, Ho T, Davies OG: Laparoscopic Roux-en-Y gastric-bypass for morbid obesity: technique and preliminary results of our first 400 patients. Arch Surg 2000;135:1029–1033.
  176. Courcoulas A, Schuchert M, Gatti G, Luketich J: The relationship of surgeon and hospital volume to outcome after gastric bypass surgery in Pennsylvania: a 3-year summary. Surgery 2003;134:613– 623.
  177. Sarwer DB, Moore RH, Spitzer JC, et al. A pilot study investigating ther efficacy of postoperative dietary counseling to improve outcomes after bariatric surgery. Surg Obes Relat Dis 2012; Mar 21. PMID 22551576.
  178. Kulick D, Hark L, Deen D. The bariatric surgery patient: a growing role for registered dietitians. J Am Diet Asoc 2010; 110: 593-599.
  179. Ziegler O, Sirveaux MA, Brunaud L, et al. Medical follow up after bariatric surgery: nutritional and drug issues. General recommendations for the prevention and treatment of nutritional deficiencies. Diabetes Metab 2009; 35: 544-557.
  180. Faria, SL. Dietary Protein Intake and Bariatric Surgery. Obes Surg. 2011; 21: 1798-1805.
  181. Raftopoulos I. Protein intake compliance with morbidly obese patients undergoing bariatric surgery and its effect on weight loss and biochecmical parameters. SOARD 2011; 7: 733-42.
  182. Billy H, Okerson T. Changes in body composition following gastric bypass or gastric banding. AACE 21st Annual Scientific and Clinical Congress, May 23-27, 2012, Philadephia PA; Abstract #1315.
  183. Bavaresco M, Paganini S, Pereira Lima T, et al. Nutritional course of patients submitted to bariatric surgery. ObesSurg 2010; 20:716-721.
  184. Andreu A, Moize V, Rodriguez L, et al. Protein intake, body composition, and protein status following bariatric surgery. ObesSurg 2010;20:1509-1515.
  185. Moize VL, Pi-Sunyer X, Mochari H, et al. Nutritional pyramid for post-gastric bypass patients. Obes Surg 2010; 20: 1133-1141.
  186. Padwal R, Brocks D, Sharma AM. A systematic review of drug absorption following bariatric surgery and its theoretical implications. Obes Rev 2010; 11: 41-50.
  187. Miller AD, Smith KM. Medication and nutrient administration considerations after bariatric surgery. Am J Health Syst Pharm 2006; 63: 1852-1857.
  188. Ceppa EP, Ceppa DP, Omotosho PA, et al. Algorithm to diagnose etiology of hypoglycemia after Roux-en-Y gastric bypass for morbid obesity: case series and review of the literature. Surg Obes Relat Dis 2011 2012;8:641-7.
  189. Cui Y, Elahi D, Andersen DK. Advances in the etiology and management of hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass. J Gastrointest Surg 2011; 15: 1879-1888.
  190. Bernard B, Kline GA, Service FJ. Hypoglycemia following upper gastrointestinal surgery: case report and review of the literature. BMC Gastroenterology 2010; 10: 77-80.
  191. Spanakis E, Gragnoli C. Successful medical management of status post-Roux-en-Y-gastric-bypass hyperinsulinemic hypoglycemia. Obes Surg 2009; 19: 1333-1334.
  192. Moreira RO, Moreira RBM, Machado NAM, et al. Post-prandial hypoglycemia after bariatric surgery: pharmacological treatment with verapamil and acarbose. Obes Surg 2008; 18: 1618-1621.
  193. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 381S-453S.
  194. Magee CJ, Barry J, Javed S, et al. Extended thromboprophylaxis reduces incidence of postoperative venous thromboembolism in laparoscopic bariatric surgery. Surg Obes Relat Dis 2010; 6: 322-325.
  195. Raftopoulos I, Martindale C, Cronin A, et al. The effect of extended post-discharge chemical thromboprophylaxis on venous thromboembolism rates after bariatric surgery: a prospective comparison trial. Surg Endosc 2008; 22: 2384-2391.
  196. Winegar DA, Sherif B, Pate V, et al. Venous thromboembolism after bariatric surgery performed by Bariatric Surgery Center of Excellence Participants: analysis of the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis 2011;7:181-188.
  197. The ASMBS Clinical Issues Committee. ASMBS Guideline on the prevention and detection of gastrointestinal leak after gastric bypass including the role of imaging and surgical exploration. Surg Obes Relat Dis 2009; 5: 293-296.
  198. Warschkow R, Tarantino I, Folie P, et al. C-reactive protein 2 days after laparoscopic gastric bypass surgery reliably indicates leaks and moderately predicts morbidity. J Gastrointest Surg 2012; 16: 1128-1135.
  199. Lyass S, Khalili TM, Cunneen S, et al. Radiological studies after laparoscopic Roux-en-Y gastric bypass: routine or selective? Am Surg 2004; 70: 918-921.
  200. Carussi LR, Turner MA, Conklin RC, et al. Roux-en-Y gastric bypass surgery for morbid obesity: evaluation of postoperative extraluminal leaks with upper gastrointestinal series. Radiology 2006; 238: 119-127.
  201. Miller K, Hell E: Laparoscopic surgical concepts of morbid obesity. Langenbecks Arch Surg 2003;388:375–384.
  202. Laville M, Romon M, Chavrier G, Guy-Grand B, Krempf M, Chevallier JM, et al: Recommendations regarding obesity surgery. Obes Surg 2005; 15:1476–1480.
  203. Shen R, Dugay G, Rajaram K, Cabrera I, Siegel N, Ren CJ: Impact of patient follow-up on weight loss after bariatric surgery. Obes Surg 2004;14:514–519.
  204. Favretti F, O’Brien PE, Dixon JB: Patient management after LAP-BAND placement. Am J Surg 2002;184(suppl 2): 38S–41S.
  205. Busetto L, Pisent C, Segato G, De Marchi F, Favretti F, Lise M, et al: The influence of a new timing strategy of band adjustment on the vomiting frequency and the food consumption of obese women operated with laparoscopic adjustable silicone gastric banding (LAP-BAND). Obes Surg 1997;7:505-12.
  206. Rabkin RA, Rabkin JM, Metcalf B, Lazo M, Rossi M, Lehman-Becker LB: Nutritional markers following duodenal switch for morbid obesity. Obes Surg 2004;14:84–90.
  207. Ledikwe JH, Smiciklas-Wright H, Mitchell DC, Jensen GL, Friedmann JM, Still CD: Nutritional risk assessment and obesity in rural older adults: a sex difference. Am J Clin Nutr 2003;77:551–558.
  208. Ledikwe JH, Smiciklas-Wright H, Mitchell DC, Miller CK, Jensen GL: Dietary patterns of rural older adults are associated with weight and nutritional status. J Am Geriatr Soc 2004;52:589–595.
  209. MacLean LD, Rhode B, Shizgal HN: Nutrition after vertical banded gastroplasty. Ann Surg 1987; 206:555–563.
  210. Hamoui N, Anthone G, Crookes PF: Calcium metabolism in the morbidly obese. Obes Surg 2004; 14:9–12.
  211. Faintuch J, Matsuda M, Cruz ME, Silva MM, Teivelis MP, Garrido AB Jr, et al: Severe proteincalorie malnutrition after bariatric procedures. Obes Surg 2004;14:175–181.
  212. Baltasar A, Serra C, Perez N, Bou R, Bengochea M: Clinical hepatic impairment after the duodenal switch. Obes Surg 2004;14:77–83.
  213. Boylan LM, Sugerman HJ, Driskell JA: Vitamin E, vitamin B-6, Vitamin B-12, and folate status of gastric bypass surgery patients. J Am Diet Assoc 1988;88:579–585.
  214. Cannizzo F Jr, Kral JG: Obesity surgery: a model of programmed undernutrition. Curr Opin Clin Nutr Metab Care 1998;1:363–368.
  215. Hamoui N, Kim K, Anthone G, Crookes PF: The significance of elevated levels of parathyroid hormone in patients with morbid obesity before and after bariatric surgery. Arch Surg 2003;138: 891–897.
  216. Skroubis G, Sakellaropoulos G, Pouggouras K, Mead N, Nikiforidis G, Kalfarentzos F: Comparison of nutritional deficiencies after Roux-en-Y gastric bypass and after biliopancreatic diversion with Roux-en-Y gastric bypass. Obes Surg 2002; 12:551–558.
  217. Slater GH, Ren CJ, Siegel N, Williams T, Barr D, Wolfe B, et al: Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. J Gastrointest Surg 2004;8:48–55.
  218. Halverson JD: Micronutrient deficiencies after gastric bypass for morbid obesity. Am Surg 1986; 52:594–598.
  219. Avinoah E, Ovnat A, Charuzi I: Nutritional status seven years after Roux-en-Y gastric bypass surgery. Surgery 1992;111:137–142.
  220. Brolin RE, Gorman RC, Milgrim LM, Kenler HA: Multivitamin prophylaxis in prevention of postgastric bypass vitamin and mineral deficiencies. Int J Obes Relat Metab Disord 1991;15:661–667.
  221. Rhode BM, Arseneau P, Cooper BA, Katz M, Gilfix BM, MacLean LD: Vitamin B-12 deficiency after gastric surgery for obesity. Am J Clin Nutr 1996;63:103–109.
  222. Schilling RF, Gohdes PN, Hardie GH: Vitamin B12 deficiency after gastric bypass surgery for obesity. Ann Intern Med 1984;101:501–502.
  223. Simon SR, Zemel R, Betancourt S, Zidar BL: Hematologic Complications of gastric bypass for morbid obesity. South Med J 1989; 2:1108–1110.
  224. Brolin RE, Gorman JH, Gorman RC, Petschenik AJ, Bradley LJ, Kenler HA, et al: Are vitamin B12 and folate deficiency clinically important after roux-en-Y gastric bypass? J Gastrointest Surg 1998;2:436–442.
  225. Halverson JD: Metabolic risk of obesity surgery and long term follow-up. Am J Clin Nutr 1992; 55(suppl 2):602S–605S.
  226. Goode LR, Brolin RE, Chowdhury HA, Shapses SA: Bone and gastric bypass surgery: effects of dietary calcium and vitamin D. Obes Res 2004;12: 40–47.
  227. Coates PS, Fernstrom JD, Fernstrom MH, Schauer PR, Greenspan SL: Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass. J Clin Endocrinol Metab 2004;89:1061–1065.
  228. Shaker JL, Norton AJ, Woods MF, Fallon MD, Findling JW: Secondary hyperparathyroidism and osteopenia in women following gastric exclusion surgery for obesity. Osteoporos Int 1991;1: 177–181.
  229. Abu-Abeid S, Keidar A, Gavert N, Blanc A, Szold A: The clinical spectrum of band erosion following laparoscopic adjustable silicone gastric banding for morbid obesity. Surg Endosc 2003;17:861–863.
  230. Jones KB Jr: Revisional bariatric surgery-safe and effective. Obes Surg 2001;11:183–189.
  231. Weber M, Muller MK, Michel JM, Belal R, Horber F, Hauser R, et al: Laparoscopic Roux-en-Y gastric bypass, but not rebanding, should be proposed as rescue procedure for patients with failed laparoscopic gastric banding. Ann Surg 2003;238:827–834.
  232. Dolan K, Fielding G: Bilio pancreatic diversion following failure of laparoscopic adjustable gastric banding. Surg Endosc 2004;18:60–63.
  233. Chevallier JM, Zinzindohoue F, Douard R, Blanche JP, Berta JL, Altman JJ, et al: Complications after laparoscopic adjustable gastric banding for morbid obesity: experience with 1,000 patients over 7 years. Obes Surg 2004;14:407–414.
  234. Iovino P, Angrisani L, Tremolaterra F, Nirchio E, Ciannella M, Borrelli V, et al: Abnormal esophageal acid exposure is common in morbidly obese patients and improves after a successful Lap-band system implantation. Surg Endosc 2002;16:1631–1635.
  235. Niville E, Dams A: Late pouch dilation after laparoscopic adjustable gastric and esophagogastric banding: incidence, treatment, and outcome. Obes Surg 1999;9:381–384.
  236. Sanyal AJ, Sugerman HJ, Kellum JM, Engle KM, Wolfe L: Stomal complications of gastric bypass: incidence and outcome of therapy. Am J Gastroenterol 1992;l87:165–169.
  237. Weiner R, Theodoridou S, Weiner S: Failure of laparoscopic sleeve gastrectomy--further procedure? Obes Facts 2011; 4 Suppl 1:42-6.
  238. Barba CA, Butensky MS, Lorenzo M, Newman R: Endoscopic dilation of gastroesophageal anastomosis stricture after gastric bypass. Surg Endosc 2003;17:416–420.
  239. Schauer PR, Ikrammudin S, Gourash W, Ramanathan R, Luketich J: Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity.Ann Surg 2000;232:515–529.
  240. Spaulding L: Treatment of dilated gastrojejunos tomy with sclerotherapy. Obes Surg 2003;13: 254–257.
  241. Anthone GJ, Lord RV, DeMeester TR, Crookes PF: The duodenal switch operation for the treatment of morbid obesity. Ann Surg 2003;238: 618–628.
  242. Bloomberg RD, Urbach DR: Laparoscopic Rouxen- Y gastric bypass for severe gastroesophageal reflux after vertical banded gastroplasty. Obes Surg 2002;12:408–11.
  243. Cowan GS Jr., Bariatric surgical utterances: need they be dogmatic? Obes Surg 1999 9:3-4.
  244. Cowan GS Jr. Obligations of the bariatric surgeon. Obes Surg 2000 10:498-501.
  245. Must A., Spadano J., Coakley E. et al. The disease burden associated with overweight and obesity. JAMA 1999, 282, 1523-1529
  246. Guh D World Health Organisation. Obesity: preventing and managing the global epidemic. 1997, Geneva:WHO
  247. Lenz M Freedman D., Ron E., Ballard-Barbash R. et al. Body mass index and all-cause mortality in a nationwide US cohort. Int J Obes (Lond) 2006; 30: 822-9
  248. Bernstein D. Cardiovascular physiology. In Morbid Obesity. Perioperative management. Edited by Alvarez A. 2nd Edition. Cambridge University Press 2010
  249. Herpertz S, Kielmann R, Wolf A. et al. Do psychosocial variables predict weight loss or mental health after obesity surgery? A systematic review. Obes Res 2004;12:1554-69
  250. Kalarchian M., Marcus M., Levine M. et al. Relationship of psychiatric disorders to 6-month outcomes after gastric bypass. Surg Obes Relat Dis 2008; 4: 544-9
  251. Sarwer D., Cohn N., Gibbons L. et al. Psychiatric diagnoses and psychiatric treatment among bariatric surgery candidates. Obes Surg 2004; 14: 1148-56.
  252. Brechner R., Farris C., Harrison S. et al. A graded evidence-based summary of evidence for bariatric surgery. Surg Obes Relat Dis 2005; 1: 430-441
  253. Interdisciplinary European guidelines for surgery for severe (morbid) obesity. Obes Surg 2007; 17: 260-70
  254. American association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic and Bariatric Surgery Medical Guidelines for Clinical Practice for the perioperative nutritional, metabolic and non-surgical support of the bariatric surgery patient. Surg Obes Relat Dis 2008; 4(5 Suppl): S109-84
  255. Management of obstructive sleep apnoea/hypopnoea syndrome in adults. A national clinical guideline. Scottish Intercollegiate Guidelines Network - National Government Agency [Non-U.S.]. 2003 June
  256. Practice parameters for the indications for polysomnography and related procedures: an update for 2005. American Academy of Sleep Medicine - Professional Association. 1997 (revised 2005 Apr 1)
  257. Kushida CA, Littner MR, Hirshkowitz M, Morgenthaler TI, Alessi CA, Bailey D, Boehlecke B, Brown TM, Coleman J Jr, Friedman L, Kapen S, Kapur VK, Kramer M, Lee-Chiong T, Owens J, Pancer JP, Swick TJ, Wise MS, American Academy of Sleep Medicine. Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep 2006 Mar 1; 29(3):375-80
  258. Screening for obstructive sleep apnea in the primary care setting. University of Texas at Austin School of Nursing, Family Nurse Practitioner Program - Academic Institution. 2006 May.
  259. Hsu L., Benotti P., Dwyer J. Nonsurgical factors that influence the outcome of bariatric surgery: a review. Psychosom Med 1998; 60: 338-46
  260. Yang C., Lee W., Wang H. et al. The influence of Helicobacter pylori infection on the development of gastric ulcer in symptomatic patients after bariatric surgery. Obes Surg 2006; 16: 735-739
  261. AACE Diabetes Mellitus Clinical Practice Guidelines Task Force. American Association of Clinical Endocrinologists medical guideline for clinical management of diabetes mellitus. Endocr Pract 2004; 10: 112-118
  262. Постановление Международной федерации хирургии ожирения (IFSO) от 5 сентября 1999 года. Obesity Surgery 1999; 9: 291
  263. Polk H., Christmas A. Prophylactic antibiotics in surgery and surgical wounds infections. Am Surg 2000; 66:105-111
  264. Mognol P., Vignes S., Chosidow P. et al. Rhabdomyolysis after laparoscopic bariatric surgery. Obes Surg 2004; 14: 91-94
  265. De Freitas Carvalho D., Valezi A., de Brito E. et al. Rhabdomyolysis after bariatric surgery. Obes Surg 2006; 16: 740-744
  266. Dronge A., Percal H., Kancir S. et al. Long-term glycemic control and postoperative infectious complications. Arch Surg 2006; 141: 375-380
  267. Service G., Thompson G., Service F. et al. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric bypass surgery. N Engl J Med 2005; 353: 249-54
  268. Goldfine A., Mun E., Devine E. et al. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin responses to a mixed meal. J Clin Endocrinol Metab 2007; 92: 4678-85
  269. Brolin R., Kenler H., Wilson A. et al. Serum lipids after gastric bypass surgery for morbid obesity. Int J Obes 1990; 14: 939-50
  270. Brolin R., Bradely L., Wilson A. et al. Lipid risk profile and weight stability after gastric restrictive operations for morbid obesity. J Gastroenterol Surg 2000; 4: 464-69
  271. Martin L., Finigan K., Nolan T. Pregnancy after adjustable gastric banding. Obstetr Gynecol 2000; 95(6, pt 1): 927-930
  272. Gerrits E., Ceulemans R., van hee R. et al. Contraceptive treatment after biliopancreatic diversion needs consensus. Obes Surg 2001; 11: 303-306
  273. Яшков Ю.И. Стандарты в бариатрической хирургии. Ожирение и метаболизм 2008 №3, стр.16-18
  274. Brady M, Kinn S, Stuart P. Preoperative fasting for adults to prevent perioperative complications. The Cochrane database of systematic reviews 2003, DOI: 10.1002/14651858.CD004423: CD004423
  275. McLeod R, Fitzgerald W, Sarr M et al. Canadian Association of General Surgeons and American College of Surgeons evidence based reviews in surgery. 14. Preoperative fasting for adults to prevent perioperative complications. Canadian journal of surgery Journal canadien de chirurgie 2005; 48: 409-411
  276. Noblett SE, Watson DS, Huong H et al. Pre-operative oral carbohydrate loading in colorectal surgery: a randomized controlled trial. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 2006; 8: 563-569
  277. Soop M, Nygren J, Myrenfors P et al. Preoperative oral carbohydrate treatment attenuates immediate postoperative insulin resistance. American journal of physiology Endocrinology and metabolism 2001; 280: E576-583
  278. Wille-Jorgensen P, Guenaga KF, Matos D et al. Pre-operative mechanical bowel cleansing or not? an updated meta-analysis. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 2005; 7: 304-310
  279. Jung B, Pahlman L, Nystrom PO et al. Multicentre randomized clinical trial of mechanical bowel preparation in elective colonic resection. The British journal of surgery 2007; 94: 689-695
  280. Gross JB, Bachenberg KL, Benumof JL et al. Practice guidelines for the perioperative management of patients with obstructive sleep apnea: a report by the American Society of Anesthesiologists Task Force on Perioperative Management of patients with obstructive sleep apnea. Anesthesiology 2006; 104: 1081-1093; quiz 1117-1088
  281. Hillman DR, Platt PR, Eastwood PR. Anesthesia, sleep, and upper airway collapsibility. Anesthesiology clinics 2010; 28: 443-455
  282. Aubrun F, Valade N, Coriat P et al. Predictive factors of severe postoperative pain in the postanesthesia care unit. Anesthesia and analgesia 2008; 106: 1535-1541, table of contents
  283. Apfel CC, Heidrich FM, Jukar-Rao S et al. Evidence-based analysis of risk factors for postoperative nausea and vomiting. British journal of anaesthesia 2012; 109: 742-753
  284. Mansour MA, Mahmoud AA, Geddawy M. Nonopioid versus opioid based general anesthesia technique for bariatric surgery: A randomized double-blind study. Saudi journal of anaesthesia 2013; 7: 387-391
  285. dos Santos Moraes I, Jr., Madalosso CA, Palma LA et al. Hospital discharge in the day following open Roux-en-Y gastric bypass: is it feasible and safe? Obes Surg 2009; 19: 281-286
  286. Moussa AA, Oregan PJ. Prevention of postoperative nausea and vomiting in patients undergoing laparoscopic bariatric surgery--granisetron alone vs granisetron combined with dexamethasone/droperidol. Middle East journal of anesthesiology 2007; 19: 357-367
  287. Golembiewski J, Chernin E, Chopra T. Prevention and treatment of postoperative nausea and vomiting. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2005; 62: 1247-1260; quiz 1261-1242
  288. Karanicolas PJ, Smith SE, Kanbur B et al. The impact of prophylactic dexamethasone on nausea and vomiting after laparoscopic cholecystectomy: a systematic review and meta-analysis. Annals of surgery 2008; 248: 751-762
  289. Mendes MN, Monteiro Rde S, Martins FA. Prophylaxis of postoperative nausea and vomiting in morbidly obese patients undergoing laparoscopic gastroplasties: a comparative study among three methods. Revista brasileira de anestesiologia 2009; 59: 570-576
  290. Benevides ML, Oliveira SS, de Aguilar-Nascimento JE. The combination of haloperidol, dexamethasone, and ondansetron for prevention of postoperative nausea and vomiting in laparoscopic sleeve gastrectomy: a randomized double-blind trial. Obes Surg 2013; 23: 1389-1396
  291. Henzi I, Walder B, Tramer MR. Dexamethasone for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesthesia and analgesia 2000; 90: 186-194

 

Для продолжения работы требуется Регистрация
На предыдущую страницу

Предыдущая страница

Следующая страница

References
На предыдущую главу Предыдущая глава
оглавление
Следующая глава

Оглавление

Данный блок поддерживает скрол*